✦ LIBER ✦

Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor

✍ Scribed by Sheryl R. Torr; Ethan J. Haskel; Philip F. VonVoigtlander; Steven R. Bergmann; Dana R. Abendschein

Book ID: 119167995
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 388 KB
Volume: 18
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(91)90524-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alterations in endocardial vascular resi

Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist

✍ Erwin Schröder; Hubert Pouleur; Henri Van Mechelen; André Keyeux; Juan Raigoso; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Effects of a platelet activating factor

Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury

✍ Thomas Panetta; Victor L. Marcheselli; Pierre Braquet; Brigitte Spinnewyn; Nicol 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Dual effect of a new compound, rupatadin

Dual effect of a new compound, rupatadine, on edema induced by platelet-activating factor and histamine in dogs: Comparison with antihistamines and PAF antagonists

✍ Mireia Queralt; Manuel Merlos; Marta Giral; Anna Puigdemont 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

The antihistamine-H, and antiplatelet activating factor (PAF) activities of seven compounds, including rupatadine, a new antiallergic drug, were studied in healthy beagle dogs using a new experimental model that allows simultaneous testing of PAF and histamine reactions in the same animal. The metho